New Journal of the American College of Surgeons study reports that surgical treatment increases survival for metastatic melanoma patients whose disease is limited to the liver and—when combined with systemic therapy—holds promise for more patients to do well.
Surgical resection markedly improves survival among metastatic melanoma patients whose disease is isolated to a few areas in the liver, according to new study findings published in the July issue of the Journal of the American College of Surgeons. These results mark a departure for melanoma, an aggressive form of skin cancer, that is most often considered fatal once it has spread to the liver and then, not amenable to surgical treatment.
In the past, surgical treatment for liver metastases was not considered an option for most patients, as the disease typically spreads to other organs. However, advances in surgical techniques along with new systemic therapies have made existing therapies more effective and opened the door to new therapeutic approaches.
“Although there has been a great deal of excitement about the new medical therapies, which are clearly enormous advances, those are still not the answers for everyone,” said lead investigator Mark Faries, MD, FACS, Director of the Donald L. Morton, MD, Melanoma Research Program at John Wayne Cancer Institute in Santa Monica, Calif. “We’ve been proponents of metastasectomy for a long time and wanted to know how our patients who had been treated surgically for liver metastases had done.”
For the study, Dr. Faries and colleagues studied medical records of 1,078 patients who had been treated for melanoma liver metastases at their center since 1991. Of those, 58 were treated surgically with liver resection, an operation that removes the cancerous portion of the liver. In some cases, surgical treatment included local ablation therapy in addition to resection. Ablative treatments such as radiofrequency ablation or microwave ablation are used to destroy tumors in patients who are not able to have all of their metastases surgically resected.
Median overall survival among patients who underwent surgical resection was more than triple that of patients who received medical therapy without surgical treatment (24.8 months vs. 8 months). The five-year survival rate for surgical patients was 30 percent, compared with 6.6 percent for the nonsurgical group.
“What we have seen in previous studies is that many patients who are able to undergo resection of their metastatic disease from melanoma can have good long-term outcomes, which is important to remember even in an era of more effective medications,” Dr. Faries explained.
Median overall survival was similar among patients undergoing ablation (with or without resection) compared with those undergoing surgical treatment alone. The promising news is that newer technologies such as ablation may enable more metastatic melanoma patients to have surgical treatment, according to Dr. Faries.
The investigators also looked at the relationship between systemic therapy and surgical treatment. According to study authors, when patients had had their metastatic disease stabilized with systemic therapy—meaning their metastatic disease either shrank or stopped growing significantly as a result of medical therapy—and then underwent a surgical treatment, the patients whose disease had been stabilized prior to the operation did much better over the long term than those who did not have their metastatic disease stabilized.
“The presence of more effective medications may, in fact, make surgical treatment more important or may lead to new approaches that combine liver resection with these more effective medications, which may result in even better outcomes than any individual therapy alone,” Dr. Faries said.
He thinks that what holds promise for the future is the potential to combine systemic therapy with local surgical or ablative therapies. For instance, patients would undergo systemic therapy for a defined period of time and then undergo resection. “This approach could apply to liver metastases as well as metastases in other places in the body,” he said. “That path would give surgeons the opportunity to more appropriately select patients for surgical treatment and to assess their response to the new drugs.”
Study limitations include the fact that the investigation was a retrospective study spanning two decades, which means researchers were unable to control for certain factors. Additionally, since isolated liver metastases are rare in melanoma, the vast majority of the metastatic melanoma population would not be candidates for surgical resection.
“In our recent study, the fraction of patients that was able to undergo resection was higher than it had been in previous studies,” Dr. Faries said. “It is only about 1 in 20 patients that ended up being able to have the operation, but that number is still higher than it used to be.”
The bottom line, according to Dr. Faries, is that surgeons should discuss surgical resection for the treatment of melanoma liver metastases with their patients if their disease is limited to a few areas in the liver, their overall health status is good, and the disease is indolent or the patients are responding to systemic therapy.
Other study authors include Anna Leung, MD; Donald L. Morton, MD; Danielle Hari, MD; Ji-Hey Lee, PhD; Myung-shin Sim, PhD; and Anton J. Bilchik, MD, PhD, FACS.
This study was supported by grant P01CA29605 from the National Cancer Institute, Dr Miriam & Sheldon G Adelson Medical Research Foundation (Boston, MA), Borstein Family Foundation (Los Angeles, CA), The California Oncology Research Institute (Los Angeles, CA), and the John Wayne Cancer Institute Auxiliary (Santa Monica, CA). Dr. Leung was the Harold McAlister Charitable Foundation Fellow (Los Angeles, CA). Dr. Hari was the William Randolph Hearst Foundation Fellow (San Francisco, CA). Content is solely the responsibility of the authors and does not necessarily represent the official view of the National Cancer Institute or the National Institutes of Health.
Citation: Journal of the American College of Surgeons, July 2014: Vol. 219 (1) 62-68.
# # #
About the American College of Surgeons
The American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and improve the quality of care for surgical patients. The College is dedicated to the ethical and competent practice of surgery. Its achievements have significantly influenced the course of scientific surgery in America and have established it as an important advocate for all surgical patients. The College has more than 79,000 members and is the largest organization of surgeons in the world. For more information, visit www.facs.org.
Sally Garneski | Eurek Alert!
The genes are not to blame
20.07.2018 | Technische Universität München
Targeting headaches and tumors with nano-submarines
20.07.2018 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz
A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.
The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...
For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.
To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...
For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.
Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...
Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.
A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...
Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.
"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....
13.07.2018 | Event News
12.07.2018 | Event News
03.07.2018 | Event News
20.07.2018 | Power and Electrical Engineering
20.07.2018 | Information Technology
20.07.2018 | Materials Sciences